Farmas USA

No, no, no lo jures, si lo estoy viendo ...

NVAX

También pillé los 2 subidones de CYTR esta semana y las vendí con buenas pluses...
Habrá que irla siguiendo....
Ayer, tras la segunda new seguida, no acabó de animarse del todo....

CYTR

Eso es pq no había ninguna otea acción a la venta entre 6,02 y 6,34? No entiendo ese salto tan bestia pq una compra de 6 dolares!!!

Yo sigo sin vender desde q te lo dije. Mi compra media es de 2,35.

Esas son mis operaciones......cotillaaaaaaaaaaaaaaaaaaa......jajajajaj
Estás mostrando mis intimidades...............

ARNA

Filling 8-K que comunica a la SEC la noticia de la fase Ib del otro día y la continuación de fase II es este año. Nada nuevo.

ARNA

Comunicado de ampliación del programa de marketing de Eisai y del equipo de ventas. Importante es que comenta que hay un número creciente de seguros que la cubren y crean una campaña específica que se dirige a los pacientes sin cubrir.

Encouraged by the increasing number of payers who have made the decision to provide formulary coverage for BELVIQ, Eisai will continue to focus on expanding managed care and employer coverage in the year ahead. For patients who do not have health insurance coverage for BELVIQ, Eisai plans on launching a new program next week to help improve access and affordability. Additionally, Eisai plans to expand its consumer outreach efforts, and the BELVIQ sales force will consist of 450 representatives strategically focused on health care providers who may prescribe pharmacotherapy for weight management.

"At the time of FDA approval, BELVIQ was the first new prescription drug for weight management in over a decade, and since then approximately 275,000 patients have initiated therapy," said Jack Lief, Arena's President and Chief Executive Officer. "Eisai's updated sales and marketing initiatives, including its plans to increase the access and affordability of BELVIQ for a greater number of patients, as well as the strategic focus of its sales force, are being launched at a time of year when we historically see a renewed interest by patients and physicians to address weight management."

NVAX

Así me gusta, que calientes el valor en PM, y todos los usanos detrás!